Interactions between statins and the farnesoid-X-receptor inhibit positive effects of chenodeoxycholic acid on insulin secretion

被引：0
|
作者：
Hoffmeister, T. [1 ]
Kaiser, J. [2 ]
Drews, G. [2 ]
Duefer, M. [1 ]
机构：
[1] Inst Pharmaceut & Med Chem, Dept Pharmacol, Munster, Germany
[2] Inst Pharm, Dept Pharmacol & Clin Pharm, Tubingen, Germany
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
398
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [1] Statins inhibit insulinotropic effects of chenodeoxycholic acid by interacting with the farnesoid-X-receptor
    Hoffmeister, T.
    Kaiser, J.
    Drews, G.
    Duefer, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S26 - S26
  • [2] Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis
    Fiorucci, Stefano
    Distrutti, Eleonora
    Biagioli, Michele
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (11) : 3668 - 3671
  • [3] Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis
    Stefano Fiorucci
    Eleonora Distrutti
    Michele Biagioli
    Digestive Diseases and Sciences, 2021, 66 : 3668 - 3671
  • [4] Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia/reperfusion injury in mice
    Gao, Yi
    Zhao, Yichao
    Yuan, Ancai
    Xu, Longwei
    Huang, Xian
    Su, Yuanyuan
    Gao, Lingchen
    Ji, Qingqi
    Pu, Jun
    He, Ben
    EXPERIMENTAL CELL RESEARCH, 2018, 371 (02) : 301 - 310
  • [5] Statins inhibit cytosolic effects of the farnesoid X receptor in murine β-cells by an HMGCoA reductase-dependent mechanism
    Luedtke, S.
    Hoffmeister, T.
    Drews, G.
    Duefer, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 37 - 38
  • [6] 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor
    Honjo, Y
    Sasaki, S
    Kobayashi, Y
    Misawa, H
    Nakamura, H
    JOURNAL OF ENDOCRINOLOGY, 2006, 188 (03) : 635 - 643
  • [7] Farnesoid X-Receptor Agonists Inhibit Colonic Secretion In Vitro and In Vivo
    Keating, Niamh
    Mroz, Magdalena S.
    Dunleavy, Fiona
    Ward, Joseph B.
    Keely, Stephen J.
    GASTROENTEROLOGY, 2010, 138 (05) : S589 - S589
  • [8] Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis
    Fiorucci, S
    Clerici, C
    Antonelli, E
    Orlandi, S
    Goodwin, B
    Sadeghpour, BM
    Sabatino, G
    Russo, G
    Castellani, D
    Willson, TM
    Pruzanski, M
    Pellicciari, R
    Morelli, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (02): : 604 - 612
  • [9] Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase
    Miyata, Masaaki
    Matsuda, Yoshiki
    Tsuchiya, Hiroyuki
    Kitada, Hirotaka
    Akase, Takanori
    Shimada, Miki
    Nagata, Kiyoshi
    Gonzalez, Frank J.
    Yamazoe, Yasushi
    DRUG METABOLISM AND PHARMACOKINETICS, 2006, 21 (04) : 315 - 323
  • [10] Farnesoid X receptor alpha ligands inhibit in vitro HDV replication and virion secretion and infectivity
    Lacombe, Benoit
    Lucifora, Julie
    Menard, Camille
    Legrand, Anne-Flore
    Maud, Michelet
    Foca, Adrien
    Abrial, Pauline
    Lotteau, Vincent
    Andre, Patrice
    Durantel, David
    Ramiere, Christophe
    JOURNAL OF HEPATOLOGY, 2021, 75 : S698 - S698
12345